WAYNE, Pa.–(BUSINESS WIRE)–Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo Securities 2018 Healthcare Conference at the Westin Copley Place in Boston, MA, Wednesday, September 5, 2018 at 4:10 p.m. (ET). A live audio webcast of the conference presentation, along with the […]
Other News
AtriCure to Present at the Morgan Stanley Global Healthcare Conference
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt Hotel in New York on Friday, September 14, 2018. Management is scheduled to present […]
SANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to Report on a 300% Increase in Revenue
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) — (OTCQB:SNWV) — SANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to report on a 300% increase in revenue. The interview began with Jolly noting, “You know, you guys knocked it out of the park. You just […]
HeartSciences Showcases MyoVista® Wavelet ECG at 2018 European Society of Cardiology Congress (ESC)
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing and artificial intelligence, is proud to announce its participation as an exhibitor at the upcoming 2018 European Society of Cardiology Congress (ESC). The Congress will take place at Messe Munich International […]
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa® (dabigatran etexilate)
NGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCITM trial and GLORIATM-AF Registry Program at the upcoming ESC Congress 2018, organised by the European Society of Cardiology, taking place in Munich, Germany on the 25-29 August 2018. The primary data from these studies have contributed […]
BioSig Appoints Johnson & Johnson Veteran Amy Scott
Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has partnered with Mrs. Amy Ansfield Scott in order […]
Capital Health First in New Jersey to Offer FDA-Approved EMBOTRAP II Stent Retriever for Ischemic Stroke Patients
TRENTON, N.J., Aug. 20, 2018 /PRNewswire/ — Capital Health is the first hospital in New Jersey, and among the first in the United States, to use the new EMBOTRAP II Revascularization Device since its recent approval from the US Food and Drug Administration (FDA) in July. As part of its Comprehensive Stroke Center, neurosurgeons […]
Vascular Graft Solutions Reports the First Clinical Use of Its FRAME External Support Technology in Aneurysm Repair of High Flow Arteriovenous Fistulas
TEL AVIV, Israel, Aug. 20, 2018 /PRNewswire/ — Vascular Graft Solutions reports the first clinical use of its FRAME external support technology for aneurysm repair in high flow arteriovenous (AV) fistulas. The first 5 cases were performed by Dr. Vladimir Matoussevitch from Cologne University Hospital in Germany. “Autogenous AV fistula access for hemodialysis is a […]
Thrombosis Research Institute (TRI) to Announce New Real-World Insights in Atrial Fibrillation at ESC Congress 2018
MUNICH, August 20, 2018 /PRNewswire/ — Satellite symposium will highlight the breadth of evidence collected since the establishment of the registry in2009 An analysis of the comparative effectiveness of oral anticoagulants in everyday practice will be presented The economic burden of atrial fibrillation (AF) in nine European countries will be evaluated The […]
iSchemaView’s RAPID™ Approved for Use in Canada
REDWOOD CITY, Calif.–(BUSINESS WIRE)–iSchemaView, the leader in cerebrovascular imaging analysis, today announced it has received final approval for the use of the RAPID platform in Canada. The RAPID platform is designed to provide physicians with fast, fully automated, elegant and easy-to-interpret imaging that facilitates clinical decision-making around cerebrovascular disease, such […]